Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,814 | -6,817 | -3,870 | -47,599 | -41,043 |
| Depreciation Amortization | 1 | 611 | 306 | 854 | 643 |
| Other Working Capital | 329 | -1,501 | -2,132 | 508 | 3,773 |
| Other Operating Activity | 117 | 890 | 549 | 17,192 | 12,709 |
| Operating Cash Flow | $-2,368 | $-6,817 | $-5,147 | $-29,045 | $-23,918 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 772 | 576 | 576 |
| PPE Investments | N/A | 769 | -3 | -921 | -791 |
| Other Investing Activity | 0 | 0 | 0 | -2,865 | -2,315 |
| Investing Cash Flow | $N/A | $769 | $769 | $-3,210 | $-2,530 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 10,604 | 6,113 | 2,368 | 2,237 |
| Other Financing Activity | 1,167 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,167 | $10,604 | $6,113 | $2,368 | $2,237 |
| Exchange Rate Effect | N/A | -49 | -135 | -67 | -69 |
| Beginning Cash Position | 3,799 | 9,292 | 9,292 | 39,246 | 39,246 |
| End Cash Position | 2,599 | 13,799 | 10,892 | 9,292 | 14,966 |
| Net Cash Flow | $-1,201 | $4,507 | $1,600 | $-29,954 | $-24,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,368 | -6,817 | -5,147 | -29,045 | -23,918 |
| Capital Expenditure | N/A | -3 | -3 | -921 | -791 |
| Free Cash Flow | -2,368 | -6,820 | -5,150 | -29,966 | -24,709 |